Stay updated with breaking news from Celcuity Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Needham & Company LLC reissued their buy rating on shares of Celcuity (NASDAQ:CELC – Free Report) in a report issued on Friday morning, Benzinga reports. Needham & Company LLC currently has a $25.00 target price on the stock. Celcuity Stock Down 1.1 % NASDAQ:CELC traded down $0.11 during trading hours on Friday, hitting $9.89. The […]
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a new focus of traders looking for the next huge move. High short interest and steep borrowing costs are among the common traits that could lead to a short squeeze.
03.08.2023 - MINNEAPOLIS, Aug. 03, 2023 (GLOBE NEWSWIRE) - Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company focused on development of targeted therapies for oncology, today announced that it will release its financial results for the second ...
Key Insights The considerable ownership by individual investors in Celcuity indicates that they collectively have a...
Celcuity Inc. (NASDAQ:CELC – Get Rating) was the recipient of a large growth in short interest during the month of May. As of May 15th, there was short interest totalling 1,350,000 shares, a growth of 171.4% from the April 30th total of 497,500 shares. Based on an average daily volume of 76,000 shares, the days-to-cover […]